Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/sdi.12255 http://scihub22266oqcxt.onion/10.1111/sdi.12255 C4407993!4407993!24962903     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Dial 2015 ; 28 (2): 198-205 Nephropedia Template TP {{tp|p=24962903|t=2015. Thrombosis in the uremic milieu- emerging role of ?thrombolome? |pdf=|usr=}}{{24962903}} gab.com Text Thrombosis in the uremic milieu- emerging role of thrombolome JO: Semin Dial http://www.kidney.de/pget.php?&tw=1&pmid=24962903 #FOAvip Chronic kidney disease (CKD) is characterized by retention of a number of toxins, which unleash cellular damage. CKD environment with these toxins and a host of metabolic abnormalities (collectively termed as uremic milieu) is highly thrombogenic. CKD represents a strong and independent risk factor for both spontaneous venous and arterial (post-vascular injury) thrombosis. Emerging evidence points to a previously unrecognized role of some of the pro-thrombotic uremic toxins. Here we provide an overview of thrombosis in CKD and an update on indolic uremic toxins, which robustly increase tissue factor, a potent pro-coagulant, in several vascular cell-types enhancing thrombosis. This panel of uremic toxins, which we term ?thrombolome? (thrombosis and metabolome), represents a novel risk factor for thrombosis and can be further explored as biomarkers for post-vascular interventional thrombosis in patients with CKD. Twit Text FOAVip Thrombosis in the uremic milieu- emerging role of thrombolome ????Semin Dial http://www.kidney.de/pget.php?&tw=1&pmid=24962903 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24962903 #FOAvip English Wikipedia <ref>{{Cite pmid|24962903}}</ref> Thrombosis in the uremic milieu- emerging role of ?thrombolome? #MMPMID24962903 Moshe S; Francis J; Chitalia V Semin Dial 2015[Mar]; 28 (2): 198-205 PMID24962903show ga Chronic kidney disease (CKD) is characterized by retention of a number of toxins, which unleash cellular damage. CKD environment with these toxins and a host of metabolic abnormalities (collectively termed as uremic milieu) is highly thrombogenic. CKD represents a strong and independent risk factor for both spontaneous venous and arterial (post-vascular injury) thrombosis. Emerging evidence points to a previously unrecognized role of some of the pro-thrombotic uremic toxins. Here we provide an overview of thrombosis in CKD and an update on indolic uremic toxins, which robustly increase tissue factor, a potent pro-coagulant, in several vascular cell-types enhancing thrombosis. This panel of uremic toxins, which we term ?thrombolome? (thrombosis and metabolome), represents a novel risk factor for thrombosis and can be further explored as biomarkers for post-vascular interventional thrombosis in patients with CKD. äThrombosis in the uremic milieu- emerging role of ?thrombolome? (epmc).pdf DeepDyve Pubget Overpricing